MIAMI — When leaders of Florida’s most populous county met in September to pick a site for what could become the nation’s largest trash incinerator, so many people went to the government center to protest that overflow seating spilled into the building’s atrium. “MIRAMAR SAYS NO TO INCINERATOR! NOT IN OUR BACKYARD,” read green T-shirts…
LAS VEGAS — Maurice Clark huddled in his tent along dusty railroad tracks as two homeless-outreach workers began asking him questions to determine whether he would qualify for free or subsidized housing. Did he use drugs? Had he ever been in jail? How many times had he been to an emergency room? Had he been…
LAS VEGAS — Case manager Bryon Johnson flashed a light into a dark tunnel beneath the glitz of the Las Vegas Strip on a recent fall afternoon. He stepped into an opening in a concrete ditch littered with trash and discarded clothing to search an underground world for his homeless clients. Beneath the Caesars Palace…
“An Arm and a Leg” updates a popular episode from 2019 — a story about giving. In 1980, a young father named Denny Buehler was battling leukemia and needed to travel from Ohio to Seattle for treatment. To raise money for the trip, his friends and family organized a softball tournament. Denny passed away a…
John Zutter is the CEO of Lantern Care which is a company managing specialty care. It has evolved from a centers of excellence model, and changed its name from Employers Direct earlier this year. The trick is product expansion into the expensive stuff, especially cancer care, infusion and specialty surgery. John has thought a lot…
Zepbound’s clinical tests in obstructive sleep apnea showed improvement in breathing disruptions that were accompanied by reductions in body weight. The new approval gives the Eli Lilly medicine the opportunity to become a blockbuster seller in yet another indication. The post Eli Lilly’s Zepbound Becomes First FDA-Approved Drug Therapy for Sleep Apnea appeared first on…
Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for the company, some experts say. The post Why Walgreens Is Reportedly Considering a Private Equity Buyer appeared first on MedCity News.
Dexcom recently became the first medical device company to embed generative AI into a continuous glucose monitor. Adding generative AI to the company’s Stelo glucose monitor will give users more personalized recommendations about how to improve their metabolic health, said Dexcom COO Jake Leach. The post Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM…
As we all work to wrap up the year and enter into 2025, here are a few trends to keep your eye on in the coming months and beyond. The post 2025 and Beyond: Key Trends to Watch in Pharmacy appeared first on MedCity News.